Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Escalation of Chinese Herbs (HLXL) in Knee Osteoarthritis
NCT00755326Phase 2Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Apr 2007
- Primary completion
- Apr 2010
- Modality
- Nucleic Acid-Directed Small Molecules, Covalent Small Molecules, Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Huoluo Xiaotong in knee osteoarthritis (OA), sponsored by University of Maryland, Baltimore. Started Apr 2007; status: completed.
02
Drugs
Huoluo Xiaotong
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00755326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00755326.